ICR Documents

Supporting Statement A Document Date Uploaded CMS -10844 Initial Price Applicability Year 2028 Negotiation Program Drug Selection Information Collection Supporting Statement - Part A.docx 11/07/2025 Supporting Statement B Document Date Uploaded Supplementary Documents Title Document Document Type Date Uploaded Crosswalk (60day changes) CMS-10844 Crosswalk.pdf Supplementary Document 09/30/2025 Crosswalk (60day to 30day changes) CMS-10844 Initial Price Applicability Year 2028 60-day to 30-day Negotiation Program Drug Selection ICR Crosswalk.pdf Supplementary Document 09/30/2025 Response to comment document (60day) CMS-10844 Initial Price Applicability Year 2028 60-day Negotiation Program Drug Selection ICR Responses to Public Comments.pdf Supplementary Document 09/30/2025 Response to comment document (30day) CMS-10844 Initial Price Applicability Year 2028 60-day and 30-day Negotiation Program Drug Selection ICR Responses to Public Comments.docx Supplementary Document 11/07/2025 Crosswalk (30day changes) CMS-10844 Initial Price Applicability Year 2028 30-day to Final Negotiation Program Drug Selection ICR Crosswalk.docx Supplementary Document 11/07/2025 Public Comments Author Name Comment Document Author Affiliation Sponsoring Org. Type Category Date of Comment Date Comment Received Chang, Shion NHC Comments RE CMS Revised IPAY ICR 2028_103025.pdf PC_202509-0938-014_103025_053023_1.pdf National Health Council National Health Council Other -- Reginfo.gov Simple 10/30/2025 10/30/2025 Calkins, Melody Biotechnology Innovation Organization.pdf Director, Health Policy Biotechnology Innovation Organization Email Simple 07/14/2025 07/14/2025 Anonymous, Anonymous CMS-2025-0048-DRAFT-0001.html.pdf Email Simple 05/23/2025 05/23/2025 Verb, Katie Bristol Myers Squibb.pdf Executive Director, Policy & Reimbursement and Strategic Alliances U.S. Policy & Government Affairs Bristol Myers Squibb Email Simple 07/14/2025 07/14/2025